Early stopping of clinical trials (Commentary)

- Cuzick, J, Howell, A, Forbes, John

Is chemotherapy necessary for premenopausal women with lower-risk node-positive, endocrine responsive breast cancer? 10-Year update of International Breast Cancer Study Group Trial 11-93

- Thürlimann, Beat, Price, Karen N., Goldhirsch, Aron, Gelber, Richard D., Holmberg, Stig B., Crivellari, Diana, Colleoni, Marco, Collins, John, Forbes, John F., Castiglione-Gertsch, Monica, Coates, Alan S.

Immunohistochemical BAG1 expression improves the estimation of residual risk by IHC4 in postmenopausal patients treated with anastrazole or tamoxifen: a TransATAC study

- Afentakis, Maria, Dowsett, Mitch, Sestak, Ivana, Salter, Janine, Howell, Tony, Buzdar, Aman, Forbes, John, Cuzick, Jack

Combination breast cancer chemotherapy with doxorubicin and cyclophosphamide damages bone and bone marrow in a female rat model

- Fan, Chiaming, Georgiou, Kristen R., Morris, Howard A., McKinnon, Ross A., Keefe, Dorothy M. K., Howe, Peter R., Xian, Cory J.

The impact of breast cosmetic and functional outcomes on quality of life: long-term results from the St. George and Wollongong randomized breast boost trial

- Hau, Eric, Browne, Lois, Capp, Anne, Delaney, Geoff P., Fox, Christopher, Kearsley, John H., Millar, Ewan, Nasser, Elias H., Papadatos, George, Graham, Peter H.

Genetic contribution to all cancers: the first demonstration using the model of breast cancers from Poland stratified by age at diagnosis and tumour pathology

- Lubiński, Jan, Korzeń, Marcin, Huzarski, Tomasz, Byrski, Tomasz, Gronwald, Jacek, Masojć, Bartłomiej, Lener, Marcin, Szymańska, Anna, Szymańska-Pasternak, Jolanta, Serrano-Fernàndez, Pablo, Piegat, Andrzej, Uciński, Rafał, Górski, Bohdan, Scott, Rodney, Cybulski, Cezary, Dębniak, Tadeusz, Jakubowska, Anna, Jaworska, Katarzyna, Wokołorczyk, Dominika, Mędrek, Krzysztof, Matyjasik, Joanna

Predictive value and clinical utility of centrally assessed ER, PgR, and Ki-67 to select adjuvant endocrine therapy for premenopausal women with hormone receptor-positive, HER2-negative early breast cancer: TEXT and SOFT trials

- Regan, Meredith M., Pagani, Olivia, Villani, Laura, Pizzolitto, Stefano, Öhlschlegel, Christian, Sessa, Fausto, Peg Cámara, Vicente, Rodríguez Peralto, José Luis, MacGrogan, Gaëtan, Colleoni, Marco, Goldhirsch, Aron, Price, Karen N., Francis, Prudence A., Coates, Alan S., Gelber, Richard D., Viale, Giuseppe, Fleming, Gini F., Walley, Barbara A., Kammler, Roswitha, Dell'Orto, Patrizia, Russo, Leila, Szőke, János, Doimi, Franco

Reevaluation of RINT1 as a breast cancer predisposition gene

- Li, Na, Thompson, Ella R., Gorringe, Kylie L., James, Paul A., Campbell, Ian G., Rowley, Simone M., McInerny, Simone, Devereux, Lisa, Goode, David, LifePool Investigators,, Wong-Brown, Michelle W., Scott, Rodney J., Trainer, Alison H.

Is adjuvant chemotherapy of benefit for postmenopausal women who receive endocrine treatment for highly endocrine-responsive, node-positive breast cancer? International Breast Cancer Study Group Trials VII and 12-93

- Pagani, Olivia, Gelber, Shari, Thürlimann, Beat, Fey, Martin F., Murray, Elizabeth, Forbes, John F., Coates, Alan S., Goldhirsch, Aron, Simoncini, Edda, Castiglione-Gertsch, Monica, Price, Karen N., Gelber, Richard D., Holmberg, Stig B., Crivellari, Diana, Collins, John, Lindtner, Jurij

Systemic targeting of metastatic human breast tumor xenografts by Coxsackievirus A21

- Skelding, Kathryn A., Barry, Richard D., Shafren, Darren R.

BRCA1-associated breast and ovarian cancer risks in Poland: no association with commonly studied polymorphisms

- Jakubowska, Anna, Gronwald, Jacek, Eils, Roland, Lubińki, Jan, Scott, Rodney J., Hamann, Ute, Menkiszak, Janusz, Górski, Bohdan, Huzarski, Tomasz, Byrski, Tomasz, Toloczko-Grabarek, Aleksandra, Gilbert, Michael, Edler, Lutz, Zapatka, Marc

Prevalence of BRCA1 and BRCA2 germline mutations in patients with triple-negative breast cancer

- Wong-Brown, Michelle W., Meldrum, Cliff J., Carpenter, Jane E., Clarke, Christine L., Narod, Steven A., Jakubowska, Anna, Rudnicka, Helena, Lubinski, Jan, Scott, Rodney J.

Functional importance of PP2A regulatory subunit loss in breast cancer

- Watt, Lauren F., Panicker, Nikita, Mannan, Abdul, Copeland, Ben, Kahl, Richard G. S., Dun, Matthew D., Young, Barbara, Roselli, Severine, Verrills, Nicole M.

Reproducibility of visual assessment on mammographic density

- Gao, Jinnan, Warren, Ruth, Warren-Forward, Helen, Forbes, John F.

Genes associated with histopathologic features of triple negative breast tumors predict molecular subtypes

- Purrington, Kristen S., Visscher, Daniel W., Kotoula, Vassiliki, Fountzilas, George, Kabisch, Maria, Rüdiger, Thomas, Heikkilä, Päivi, Blomqvist, Carl, Cross, Simon S., Southey, Melissa C., Olson, Janet E., Gilbert, Judy, Wang, Chen, Scott, Rodney, Yannoukakos, Drakoulis, Hamann, Ute, Nevanlinna, Heli, Cox, Angela, Giles, Graham G., Eckel-Passow, Jeanette E., Lakis, Sotiris

Symptoms of endocrine treatment and outcome in the BIG 1-98 study

- Huober, J., Cole, B. F., Smith, I., Wardley, A., Price, K. N., Goldhirsch, A., Coates, A. S., Colleoni, M., Gelber, R. D., Thürlimann, B., Rabaglio, M., Giobbie-Hurder, A., Wu, J., Ejlertsen, B., Bonnefoi, H., Forbes, J. F., Neven, P., Láng, I.

Weight change associated with anastrozole and tamoxifen treatment in postmenopausal women with or at high risk of developing breast cancer

- Sestak, Ivana, Harvie, Michelle, Howell, Anthony, Forbes, John F., Dowsett, Mitch, Cuzick, Jack

Vitamin D receptor variants and breast cancer risk in the Polish population

- Gapska, P., Scott, R. J., Dębniak, T., Serrano-Fernandez, P., Huzarski, T., Byrski, T., Kładny, J., Gronwald, J., Górski, B., Cybulski, C., Lubinski, J.

BRIP1, PALB2, and RAD51C mutation analysis reveals their relative importance as genetic susceptibility factors for breast cancer

- Wong, Michelle W., Nordfors, Cecilia, Mossman, David, Pecenpetelovska, Gordana, Avery-Kiejda, Kelly A., Talseth-Palmer, Bente, Bowden, Nikola A., Scott, Rodney J.

Familial association of laryngeal, lung, stomach and early-onset breast cancer

- Jaworowska, Ewa, Serrano-Fernandez, Pablo, Lubinski, Jan, Tarnowska, Czeslawa, Lubinski, Jakub, Brzosko, Marek, Flicinski, Jacek, Masojc, Bartolomej, Matyjasik, Joanna, Scott, Rodney J., Narod, Steven A.